Search Results - "Voorn, D.A."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines by Bergman, A.M, Kuiper, C.M, Voorn, D.A, Comijn, E.M, Myhren, F, Sandvold, M.L, Hendriks, H.R, Peters, G.J

    Published in Biochemical pharmacology (01-02-2004)
    “…1-β- d-Arabinofuranosylcytosine (ara-C) is a deoxycytidine analog with activity in leukemia, which requires phosphorylation by deoxycytidine kinase (dCK) to…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors by van Moorsel, C.J.A., Kroep, J.R., Pinedo, H.M., Veerman, G., Voorn, D.A., Postmus, P.E., Vermorken, J. B., van Groeningen, C.J., van der Vijgh, W.J.F., Peters, G.J.

    Published in Annals of oncology (01-04-1999)
    “…Purpose: To determine possible schedule dependent pharmacokinetic and pharmacodynamic interactions between gemcitabine (2',2'-difluorodeoxycytidine, dFdC) and…”
    Get full text
    Journal Article
  3. 3

    Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours by van Moorsel, C.J.A, Pinedo, H.M, Smid, K, Comijn, E.M, Voorn, D.A, Veerman, G, Lakerveld, B, Van der Vijgh, W.J.F, Giaccone, G, Postmus, P.E, Peters, G.J

    Published in European journal of cancer (1990) (01-12-2000)
    “…The combination of 2′,2′-difluorodeoxycytidine (gemcitabine, dFdC) and cis-diammine-dichloroplatinum(II) (cisplatin, CDDP) is increasingly applied in clinical…”
    Get full text
    Journal Article
  4. 4

    A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia by Rots, M.G., Pieters, R., Jansen, G., Kaspers, G.J.L., Van Zantwijk, C.H., Noordhuis, P., Voorn, D.A., Van Wering, E.R., Creutzig, U., Veerman, A.J.P., Peters, G.J.

    Published in European journal of cancer (1990) (01-03-2001)
    “…Acute myeloid leukaemia (AML) is thought to be methotrexate (MTX)-resistant. However, a small study suggested that acute monocytic leukemia (AML-M5) is…”
    Get full text
    Journal Article
  5. 5